Effects_of_recombinant_human_tumor_necrosis_factor_on_rodent_gliomas_and_normal_brain._In_a_study_examining_the_possible_therapeutic_effects_of_recombinant_human_tumor_necrosis_factor-alpha_(rHuTNF-alpha)_on_malignant_gliomas_without_expression_of_tumor_necrosis_factor_(TNF)-receptors,_RG-2_glioma_cells_were_tested_in_vitro_as_well_as_in_a_rat_experimental_glioma_model._A_growth_inhibition_assay_revealed_no_inhibiting_effect_in_vitro_up_to_a_concentration_of_20_micrograms/ml_rHuTNF-alpha._Receptor-binding_studies_showed_that_RG-2_cells_did_not_present_specific_receptors_for_rHuTNF-alpha._The_pharmacokinetics_of_rHuTNF-alpha_after_intravenous_injection_were_studied_with_respect_to_serum,_tissue,_and_brain_tumor_concentrations_and_showed_increased_glioma_concentrations_of_(mean_+/-_standard_error_of_the_mean)_0.47_+/-_0.18_ng_TNF/mg_brain_compared_to_0.15_+/-_0.05_ng_TNF/mg_brain_in_the_normal_contralateral_hemisphere._No_therapeutic_effect_on_solid_RG-2_gliomas_could_be_observed_after_stereotactic_injection_of_7.3_micrograms_rHuTNF/10_microliter_buffer_solution_into_the_tumor_in_10_animals._Immunohistochemical_studies_after_stereotactic_injection_of_rHuTNF-alpha_showed_total_disappearance_of_the_substance_after_24_hours_without_internalization_into_tumor_cells._Stereotactic_injection_of_7.3_micrograms_rHuTNF_10_microliters_into_normal_brain_resulted_in_marked_inflammatory_response_around_the_injection_track,_including_microvascular_thrombosis._These_results_demonstrate_that_rHuTNF_has_neither_direct_nor_indirect_cytotoxic_activity_on_RG-2_glioma_cells._Furthermore,_before_clinical_use_of_rHuTNF-alpha_in_malignant_gliomas,_the_authors_suggest_that_receptor_studies_be_done_in_each_patient._In_receptor-positive_patients_undergoing_treatment_with_rHuTNF-alpha,_precautions_should_be_taken_to_prevent_local_encephalitic_reactions.